Literature DB >> 16864582

The transcriptional activity of CITED1 is regulated by phosphorylation in a cell cycle-dependent manner.

Genbin Shi1, Scott C Boyle, Duncan B Sparrow, Sally L Dunwoodie, Toshi Shioda, Mark P de Caestecker.   

Abstract

CITED1 is the founding member of the CITED family of cofactors that are involved in regulating a wide variety of CBP/p300-dependent transcriptional responses. In the present study, we show that the phosphorylation status of CITED1 changes during the cell cycle and affects its transcriptional cofactor activity. Tryptic mapping and mutagenesis studies identified five phosphorylated serine residues in CITED1. Phosphorylation of these residues did not affect CRM1-dependent nuclear export, but did decrease CITED1 binding to p300 and inhibited CITED1-dependent transactivation of Smad4 and p300. These results suggest that CITED1 functions as a cell cycle-dependent transcriptional cofactor whose activity is regulated by phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16864582     DOI: 10.1074/jbc.M602631200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  SIX2 and CITED1, markers of nephronic progenitor self-renewal, remain active in primitive elements of Wilms' tumor.

Authors:  Andrew J Murphy; Janene Pierce; Christian de Caestecker; Chase Taylor; James R Anderson; Alan O Perantoni; Mark P de Caestecker; Harold N Lovvorn
Journal:  J Pediatr Surg       Date:  2012-06       Impact factor: 2.545

2.  CITED1 expression in Wilms' tumor and embryonic kidney.

Authors:  Harold N Lovvorn; Jenifer Westrup; Shaun Opperman; Scott Boyle; Genbin Shi; James Anderson; Elizabeth J Perlman; Alan O Perantoni; Marcia Wills; Mark de Caestecker
Journal:  Neoplasia       Date:  2007-07       Impact factor: 5.715

3.  CITED1 expression in liver development and hepatoblastoma.

Authors:  Andrew J Murphy; Christian de Caestecker; Janene Pierce; Scott C Boyle; Gregory D Ayers; Zhiguo Zhao; Jaime M Libes; Hernan Correa; Teagan Walter; Stacey S Huppert; Alan O Perantoni; Mark P de Caestecker; Harold N Lovvorn
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

4.  Validity of multiplex biomarker model of 6 genes for the differential diagnosis of thyroid nodules.

Authors:  Kristine Ducena; Arturs Abols; Janis Vilmanis; Zenons Narbuts; Juris Tārs; Diana Andrējeva; Aija Linē; Valdis Pīrāgs
Journal:  Thyroid Res       Date:  2011-06-27

5.  CITED1 confers stemness to Wilms tumor and enhances tumorigenic responses when enriched in the nucleus.

Authors:  Andrew J Murphy; Janene Pierce; Christian de Caestecker; Gregory D Ayers; Alex Zhao; Jonathan R Krebs; Vincente Kenyi Saito-Diaz; Ethan Lee; Alan O Perantoni; Mark P de Caestecker; Harold N Lovvorn
Journal:  Oncotarget       Date:  2014-01-30

6.  CITED1 contributes to the progression of papillary thyroid carcinoma via the Wnt/β-catenin signaling pathway.

Authors:  Ying Wang; Huan Huang; Fengqiong Hu; Jia Li; Lie Zhang; Hua Pang
Journal:  Onco Targets Ther       Date:  2019-08-21       Impact factor: 4.147

7.  Functional characterization of two CITED3 homologs (gcCITED3a and gcCITED3b) in the hypoxia-tolerant grass carp, Ctenopharyngodon idellus.

Authors:  Patrick K S Ng; Sung-Kay Chiu; Theresa F N Kwong; Richard M K Yu; Minnie M L Wong; Richard Y C Kong
Journal:  BMC Mol Biol       Date:  2009-11-03       Impact factor: 2.946

8.  The FGF, TGFβ and WNT axis Modulate Self-renewal of Human SIX2+ Urine Derived Renal Progenitor Cells.

Authors:  Md Shaifur Rahman; Wasco Wruck; Lucas-Sebastian Spitzhorn; Lisa Nguyen; Martina Bohndorf; Soraia Martins; Fatima Asar; Audrey Ncube; Lars Erichsen; Nina Graffmann; James Adjaye
Journal:  Sci Rep       Date:  2020-01-20       Impact factor: 4.379

9.  Intracellular Cryptococcus neoformans disrupts the transcriptome profile of M1- and M2-polarized host macrophages.

Authors:  Aarthi Subramani; Prianca Griggs; Niah Frantzen; James Mendez; Jamila Tucker; Jada Murriel; Linda M Sircy; Grace E Millican; Erin E McClelland; Rebecca L Seipelt-Thiemann; David E Nelson
Journal:  PLoS One       Date:  2020-08-28       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.